BACKGROUND: The importance of conducting substance use disorder treatment research in real-world settings is now well recognized. While this approach to clinical trials research offers a variety of benefits, challenges also arise. Selecting high-quality sites to participate is critical to recruitment, retention, and overall trial performance when conducting multi-site, community-based clinical trials of treatments for substance use disorders. OBJECTIVES: Over the past 10 years, the National Institute on Drug Abuse-sponsored National Drug Abuse Treatment Clinical Trials Network (CTN) has strived to conduct high-quality, well-managed clinical trials. This includes developing methods for site selection to be used by investigators conducting CTN trials. METHODS: We review site selection strategies from two community-based multi-site clinical trials conducted under the auspices of the National Drug Abuse Treatment Clinical Trials Network. RESULTS: Issues relevant to site selection include the clinical trial design, availability of appropriate clinical population, and organizational attributes of potential clinical research sites. Site selection strategies include reviewing regional epidemiologic data, collecting standard site selection surveys, evaluating clinic data on existing patient populations, and site selection interviews and visits. CONCLUSION: This article describes considerations for selecting research sites and identifies specific strategies to employ when selecting community-based sites for participation in clinical trials.
BACKGROUND: The importance of conducting substance use disorder treatment research in real-world settings is now well recognized. While this approach to clinical trials research offers a variety of benefits, challenges also arise. Selecting high-quality sites to participate is critical to recruitment, retention, and overall trial performance when conducting multi-site, community-based clinical trials of treatments for substance use disorders. OBJECTIVES: Over the past 10 years, the National Institute on Drug Abuse-sponsored National Drug Abuse Treatment Clinical Trials Network (CTN) has strived to conduct high-quality, well-managed clinical trials. This includes developing methods for site selection to be used by investigators conducting CTN trials. METHODS: We review site selection strategies from two community-based multi-site clinical trials conducted under the auspices of the National Drug Abuse Treatment Clinical Trials Network. RESULTS: Issues relevant to site selection include the clinical trial design, availability of appropriate clinical population, and organizational attributes of potential clinical research sites. Site selection strategies include reviewing regional epidemiologic data, collecting standard site selection surveys, evaluating clinic data on existing patient populations, and site selection interviews and visits. CONCLUSION: This article describes considerations for selecting research sites and identifies specific strategies to employ when selecting community-based sites for participation in clinical trials.
Authors: A Zweben; D M Donovan; C L Randall; D Barrett; K Dermen; E Kabela; B McRee; R Meyers; C Rice; D Rosengren Journal: J Stud Alcohol Suppl Date: 1994-12
Authors: J T Wright; W C Cushman; B R Davis; J Barzilay; P Colon; D Egan; T Lucente; C Nwachuku; S Pressel; F H Leenen; J Frolkis; R Letterer; S Walsh; J N Tobin; G E Deger Journal: Control Clin Trials Date: 2001-12
Authors: Robert F Forman; Gregory Bovasso; George Woody; Laura McNicholas; Cynthia Clark; Charlotte Royer-Malvestuto; Stephen Weinstein Journal: J Subst Abuse Treat Date: 2002-07
Authors: Dennis McCarty; Bret E Fuller; Cynthia Arfken; Michael Miller; Edward V Nunes; Eldon Edmundson; Marc Copersino; Anthony Floyd; Robert Forman; Reesa Laws; Kathy M Magruder; Mark Oyama; Kristi Prather; Jody Sindelar; William W Wendt Journal: Psychiatr Serv Date: 2007-02 Impact factor: 3.084
Authors: Leslie Amass; Walter Ling; Thomas E Freese; Chris Reiber; Jeffrey J Annon; Allan J Cohen; Dennis McCarty; Malcolm S Reid; Lawrence S Brown; Cynthia Clark; Douglas M Ziedonis; Jonathan Krejci; Susan Stine; Theresa Winhusen; Greg Brigham; Dean Babcock; Joan A Muir; Betty J Buchan; Terry Horton Journal: Am J Addict Date: 2004
Authors: Mary Hatch-Maillette; Elizabeth A Wells; Suzanne R Doyle; Gregory S Brigham; Dennis Daley; Jessica DiCenzo; Dennis Donovan; Sharon Garrett; Viviana E Horigian; Lindsay Jenkins; Therese Killeen; Mandy Owens; Harold I Perl Journal: J Subst Abuse Treat Date: 2016-06-16
Authors: Eileen Fairbanks; Shivani Shah; Mary H Wilde; Margaret V McDonald; Judith Brasch; James M McMahon Journal: Appl Nurs Res Date: 2014-04-18 Impact factor: 2.257
Authors: Elizabeth A Wells; Dennis M Donovan; Dennis C Daley; Suzanne R Doyle; Greg Brigham; Sharon B Garrett; Michelle H Ingalsbe; Mary A Hatch-Maillette; Harold I Perl; Robrina Walker Journal: J Subst Abuse Treat Date: 2014-06-14
Authors: Dennis M Donovan; Dennis C Daley; Gregory S Brigham; Candace C Hodgkins; Harold I Perl; Sharon B Garrett; Suzanne R Doyle; Anthony S Floyd; Patricia C Knox; Christopher Botero; Thomas M Kelly; Therese K Killeen; Carole Hayes; Nicole Kau'i Baumhofer; Nicole Kau'ibaumhofer; Cindy Seamans; Lucy Zammarelli Journal: J Subst Abuse Treat Date: 2012-05-31
Authors: Bart M Demaerschalk; Robert D Brown; Gary S Roubin; Virginia J Howard; Eldina Cesko; Kevin M Barrett; Mary E Longbottom; Jenifer H Voeks; Seemant Chaturvedi; Thomas G Brott; Brajesh K Lal; James F Meschia; George Howard Journal: Stroke Date: 2017-08-02 Impact factor: 7.914